Multipurpose membranes, methods for forming, and applications thereof

US10086110B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10086110-B2
Application numberUS-201314067120-A
CountryUS
Kind codeB2
Filing dateOct 30, 2013
Priority dateOct 30, 2012
Publication dateOct 2, 2018
Grant dateOct 2, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

One aspect of the present disclosure relates to a method for forming a multipurpose membrane in vivo. One step of the method includes obtaining a blood component. Next, a vacuum assembly is operated to remove substantially all of the liquid from the blood component and thereby form a concentrated, substantially dehydrated blood component. The substantially dehydrated blood component is then formed into a non-coagulated injectable composition and administered to a wound of a subject.

First claim

Opening claim text (preview).

The following is claimed: 1. An ex vivo method for forming a multipurpose membrane, the method comprising the steps of: obtaining a volume of whole blood; contacting the volume of whole blood with an amount of thrombin and a source of calcium ions to form a coagulated whole blood component; placing the coagulated whole blood component in a wicking assembly; removing a liquid from a first surface of the coagulated whole blood component; and removing a liquid from an oppositely disposed, different second surface of the coagulated whole blood component; wherein removing liquid from the first and second surfaces results in the coagulated whole blood component having a water content of less than about 10%. 2. The method of claim 1 , wherein the coagulated whole blood component is autologous, allogeneic or xenogeneic. 3. The method of claim 1 , wherein the whole blood is subjected to ultrafiltration before contacting the whole blood with the thrombin and the source of calcium ions. 4. The method of claim 1 , wherein the step of operating a vacuum assembly further comprises the steps of: providing a vacuum assembly comprising a housing having a receiving portion in fluid communication with a suction mechanism; disposing the coagulated whole blood component in the receiving portion; and operating the suction mechanism to generate a negative pressure within the receiving portion and thereby remove substantially all of the liquid from the coagulated whole blood component. 5. The method of claim 1 , wherein the placing step further comprises pouring the coagulated white blood component into a mold. 6. The method of claim 1 , being performed at about room temperature. 7. The method of claim 1 , wherein the membrane is formed in less than about 30 minutes. 8. The method of claim 1 , further including the step of imbibing the membrane with one or more therapeutic agents. 9. The method of claim 1 , wherein the coagulated whole blood component is fully coagulated after the contacting step. 10. The method of claim 1 , wherein only operation of the wicking assembly is performed to remove the liquid from the coagulated whole blood component. 11. An ex vivo method for forming a multipurpose membrane, the method consisting of: obtaining a volume of whole blood; contacting the volume of whole blood with an amount of thrombin and a source of calcium ions to form a coagulated whole blood component; placing the coagulated whole blood component in a wicking assembly; removing a liquid from a first surface of the coagulated whole blood component; and removing a liquid from an oppositely disposed, different second surface of the coagulated whole blood component; wherein removing liquid from the first and second surfaces results in the coagulated whole blood component having a water content of less than about 10%.

Assignees

Inventors

Classifications

  • for nerve reconstruction · CPC title

  • Fibrin; Fibrinogen · CPC title

  • Ingredients of undetermined constitution or reaction products thereof · CPC title

  • Ingredients of undetermined constitution or reaction products thereof · CPC title

  • Blood, e.g. platelet-rich plasma · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10086110B2 cover?
One aspect of the present disclosure relates to a method for forming a multipurpose membrane in vivo. One step of the method includes obtaining a blood component. Next, a vacuum assembly is operated to remove substantially all of the liquid from the blood component and thereby form a concentrated, substantially dehydrated blood component. The substantially dehydrated blood component is then for…
Who is the assignee on this patent?
Cleveland Clinic Found
What technology area does this patent fall under?
Primary CPC classification A61L26/0057. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).